[no definition available]
GAPDH;
EC 1.2.1.12
Timeframe | Studies on this Protein(%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
coumarin | Trypanosoma cruzi | IC50 | 691.8300 | 1 | 1 |
6-chloro-1,4-dihydro-4-oxo-1-(beta-d-ribofuranosyl)quinoline-3-carboxylic acid | Trypanosoma cruzi | Ki | 32.2700 | 1 | 1 |
quercetin | Trypanosoma cruzi | IC50 | 142.0000 | 1 | 1 |
7-hydroxycoumarin | Trypanosoma cruzi | IC50 | 616.5800 | 1 | 1 |
mangiferin | Trypanosoma cruzi | IC50 | 149.0000 | 1 | 1 |
7-hydroxy-6,4'-dimethoxyisoflavone | Trypanosoma cruzi | IC50 | 84.0000 | 1 | 1 |
tiliroside | Trypanosoma cruzi | IC50 | 46.0000 | 1 | 1 |
guajavarin | Trypanosoma cruzi | IC50 | 140.0000 | 1 | 1 |
2-hydroxy-6-[(8Z,11Z)-pentadeca-8,11,14-trien-1-yl]benzoic acid | Trypanosoma cruzi | IC50 | 28.0000 | 1 | 1 |
2-hydroxy-6-[(8Z,11Z)-pentadeca-8,11,14-trien-1-yl]benzoic acid | Trypanosoma cruzi | Ki | 4.0000 | 4 | 4 |
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
6-chloro-1,4-dihydro-4-oxo-1-(beta-d-ribofuranosyl)quinoline-3-carboxylic acid | Trypanosoma cruzi | Km | 63.3500 | 1 | 1 |